The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
The Population Dynamics and Control of Tuberculosis
Abstract
More than 36 million patients have been successfully treated via the World Health Organization’s strategy for tuberculosis (TB) control since 1995. Despite predictions of a decline in global incidence, the number of new cases continues to grow, approaching 10 million in 2010. Here we review the changing relationship between the causative agent, Mycobacterium tuberculosis , and its human host and examine a range of factors that could explain the persistence of TB. Although there are ways to reduce susceptibility to infection and disease, and a high-efficacy vaccine would boost TB prevention, early diagnosis and drug treatment to interrupt transmission remain the top priorities for control. Whatever the technology used, success depends critically on the social, institutional, and epidemiological context in which it is applied.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Infectious Diseases of Humans: Dynamics and Control
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-174_4 · Cited by 7,746
Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61697-9 · Cited by 1,988
Self-citationGandhi, N. R., Moll, A., Sturm, A. W., Pawinski, R., Govender, T., Lalloo, U., Zeller, K., Andrews, J., & Friedland, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69573-1 · Cited by 1,732
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
Barry, C. E., Boshoff, H. I., Dartois, V., Dick, T., Ehrt, S., Flynn, J., Schnappinger, D., Wilkinson, R. J., & Young, D. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2236 · Cited by 1,422
Systematic Review: T-Cell–based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update
Pai, M., Zwerling, A., & Menzies, D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00241 · Cited by 1,339
Mackay, J. M., & Eriksen, M. P. (2002) · Medical Entomology and Zoology · Cited by 1,322
Barrett, C. B. (2010) · Science · doi:10.1126/science.1182768 · Cited by 1,313
Tuberculosis and diabetes mellitus: convergence of two epidemics
Dooley, K. E., & Chaisson, R. E. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70282-8 · Cited by 932
Ramachandran, A., Wan Ma, R. C., & Snehalatha, C. (2010) · The Lancet · doi:10.1016/s0140-6736(09)60937-5 · Cited by 782
Cited by
The challenge of new drug discovery for tuberculosis
Koul, A., Arnoult, E., Lounis, N., Guillemont, J., & Andries, K. (2011) · Nature · doi:10.1038/nature09657 · Cited by 1,042
Lawn, S. D., & Zumla, A. I. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62173-3 · Cited by 751
HIV and Tuberculosis: a Deadly Human Syndemic
Kwan, C. K., & Ernst, J. D. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-10 · Cited by 720
Narasimhan, P., Wood, J., MacIntyre, C. R., & Mathai, D. (2013) · Pulmonary Medicine · doi:10.1155/2013/828939 · Cited by 731
Mycobacterium tuberculosis: success through dormancy
Gengenbacher, M., & Kaufmann, S. H. E. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2012.00331.x · Cited by 696
Modeling infectious disease dynamics in the complex landscape of global health
Heesterbeek, H., Anderson, R. M., Andreasen, V., Bansal, S., De Angelis, D., Dye, C., Eames, K. T. D., Edmunds, W. J., Frost, S. D. W., Funk, S., et al. (2015) · Science · doi:10.1126/science.aaa4339 · Cited by 690
Self-citationMinisci reactions: Versatile CH-functionalizations for medicinal chemists
Duncton, M. A. J. (2011) · MedChemComm · doi:10.1039/c1md00134e · Cited by 607
Roetzer, A., Diel, R., Kohl, T. A., Rückert, C., Nübel, U., Blom, J., Wirth, T., Jaenicke, S., Schuback, S., Rüsch-Gerdes, S., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001387 · Cited by 482
Manzanillo, P. S., Shiloh, M. U., Portnoy, D. A., & Cox, J. S. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.03.007 · Cited by 473
Wong, D., Bach, H., Sun, J., Hmama, Z., & Av-Gay, Y. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109201108 · Cited by 420
Host–pathogen coevolution in human tuberculosis
Gagneux, S. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2011.0316 · Cited by 412
Suthar, A. B., Lawn, S. D., del Amo, J., Getahun, H., Dye, C., Sculier, D., Sterling, T. R., Chaisson, R. E., Williams, B. G., Harries, A. D., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001270 · Cited by 402
Self-citationDelays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review
Sreeramareddy, C. T., Qin, Z. Z., Satyanarayana, S., Subbaraman, R., & Pai, M. (2014) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.13.0585 · Cited by 378
The global burden of tuberculosis: results from the Global Burden of Disease Study 2015
Kyu, H. H., Maddison, E. R., Henry, N. J., Mumford, J. E., Barber, R., Shields, C., Brown, J. C., Nguyen, G., Carter, A., Wolock, T. M., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30703-x · Cited by 376
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Garçon, N., & Van Mechelen, M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.29 · Cited by 314
Si, Y., Zhang, Z., Wu, W., Fu, Q., Huang, K., Nitin, N., Ding, B., & Sun, G. (2018) · Science Advances · doi:10.1126/sciadv.aar5931 · Cited by 306
Supply, P., Marceau, M., Mangenot, S., Roche, D., Rouanet, C., Khanna, V., Majlessi, L., Criscuolo, A., Tap, J., Pawlik, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2517 · Cited by 305
Quinoline: A promising antitubercular target
Keri, R. S., & Patil, S. A. (2014) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2014.10.007 · Cited by 301
Mycobacterial PE/PPE Proteins at the Host-Pathogen Interface
Sampson, S. L. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/497203 · Cited by 260
Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
Abrahams, K. A., Cox, J. A. G., Spivey, V. L., Loman, N. J., Pallen, M. J., Constantinidou, C., Fernández, R., Alemparte, C., Remuiñán, M. J., Barros, D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052951 · Cited by 177
Li, X., Yang, Y., Zhou, F., Zhang, Y., Lu, H., Jin, Q., & Gao, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015831 · Cited by 126
Feng, G., Jiang, Q., Xia, M., Lu, Y., Qiu, W., Zhao, D., Lu, L., Peng, G., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061135 · Cited by 108
RetractedBryant, J., Chewapreecha, C., & Bentley, S. D. (2012) · Future Microbiology · doi:10.2217/fmb.12.108 · Cited by 98
Phosphorylation of Mycobacterial PcaA Inhibits Mycolic Acid Cyclopropanation
Corrales, R. M., Molle, V., Leiba, J., Mourey, L., de Chastellier, C., & Kremer, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.373209 · Cited by 70
“Tuberculosis (TB)(3) caused by Mycobacterium tuberculosis (Mtb), remains a major threat to global health, claiming the life of two million individuals annually (1).”
BackgroundTorres-Romero, D., Jiménez, I. A., Rojas, R., Gilman, R. H., López, M., & Bazzocchi, I. L. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.02.034 · Cited by 54
Tuberculous Lymphadenitis and Parotitis.
Cataño, J. C., & Robledo, J. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.tnmi7-0008-2016 · Cited by 35
ChiZ levels modulate cell division process in mycobacteria
Vadrevu, I. S., Lofton, H., Sarva, K., Blasczyk, E., Plocinska, R., Chinnaswamy, J., Madiraju, M., & Rajagopalan, M. (2011) · Tuberculosis · doi:10.1016/j.tube.2011.10.022 · Cited by 28
Lopez-Lopez, N., Gonzalez-Curiel, I., Castañeda-Delgado, J., Montoya-Rosales, A., Gandara-Jasso, B., Enciso-Moreno, J. A., & Rivas-Santiago, B. (2014) · Microbes and Infection · doi:10.1016/j.micinf.2014.06.010 · Cited by 25
Xpert MTB/RIF test for detection of pulmonary tuberculosis and rifampicin resistance
Sohn, H., Pai, M., Dendukuri, N., Kloda, L. A., Boehme, C. C., & Steingart, K. R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593 · Cited by 20
Metadata
- Authors
- Dye, C., & Williams, B. G.
- Venue
- Science
- Published
- 2010-05-14
- Volume
- 328
- Issue
- 5980
- Pages
- 856-861
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2000206958
- Cited by
- 604
- References
- 43
- FWCI
- 46.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.